IL-6 Blockade Limitations as an Anticancer Strategy: Literature Review and Proposal of Explanations for Unexpected Results
Mohamed Islam Delma · Asian Oncology Research Journal · 2020
IL-6 is a cytokine with multiple protumorigenic effects, making it an interesting therapeutic target. IL-6 inhibitors with an acceptable safety profile had been developed and tested in experimental and clinical trials. However, the outcomes were not as expected theoretically. Pos...
Open access
Research Article